CD19 function in central and peripheral B-cell development
- PMID: 15778510
- DOI: 10.1385/IR:31:2:119
CD19 function in central and peripheral B-cell development
Abstract
Although the B-cell antigen receptor (BCR) factors most prominently in the maintenance and differentiation of mature B cells, it is now appreciated that co-receptor molecules can positively or negatively modulate signals through the BCR. Co-receptors are functionally defined as modifiers of BCR engagement and signal transduction, and are distinct from other accessory molecules that act independently to regulate B-cell growth. The co-receptor CD19 functions to augment signals by the pre-BCR/BCR and in doing so can modulate B-cell fate decisions at multiple stages of development. In mature B cells, CD19 also associates with complement receptor 2 (CR2/CD21) and is pivotal for transducing signals induced by co-recognition of complement C3d-fixed antigens by the BCR and CD21. In this article, we focus on recent progress in the understanding of CD19 function through the characterization of mouse models that relate in vivo function to biochemical properties of CD19.
Similar articles
-
CD19 function in early and late B cell development. II. CD19 facilitates the pro-B/pre-B transition.J Immunol. 2003 Dec 1;171(11):5921-30. doi: 10.4049/jimmunol.171.11.5921. J Immunol. 2003. PMID: 14634103
-
Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19.J Immunol. 1997 Oct 1;159(7):3278-87. J Immunol. 1997. PMID: 9317126
-
CD19 function in early and late B cell development: I. Maintenance of follicular and marginal zone B cells requires CD19-dependent survival signals.J Immunol. 2003 Jan 1;170(1):73-83. doi: 10.4049/jimmunol.170.1.73. J Immunol. 2003. PMID: 12496385
-
Regulation of peripheral B cell maturation.Cell Immunol. 2006 Feb;239(2):92-102. doi: 10.1016/j.cellimm.2006.04.007. Epub 2006 Jun 23. Cell Immunol. 2006. PMID: 16797504 Review.
-
Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex.Curr Opin Immunol. 2005 Jun;17(3):237-43. doi: 10.1016/j.coi.2005.03.001. Curr Opin Immunol. 2005. PMID: 15886112 Review.
Cited by
-
Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab-mediated complement-dependent cytotoxicity and epoxyketone-based irreversible proteasome inhibitors.Exp Hematol Oncol. 2013 Jan 10;2(1):2. doi: 10.1186/2162-3619-2-2. Exp Hematol Oncol. 2013. PMID: 23305345 Free PMC article.
-
Alteration of B-cell subsets enhances neuroinvasion in mouse scrapie infection.J Virol. 2008 Apr;82(7):3791-5. doi: 10.1128/JVI.02036-07. Epub 2008 Jan 16. J Virol. 2008. PMID: 18199638 Free PMC article.
-
Advances in adoptive cellular immunotherapy and therapeutic breakthroughs in multiple myeloma.Exp Hematol Oncol. 2024 Oct 28;13(1):105. doi: 10.1186/s40164-024-00576-6. Exp Hematol Oncol. 2024. PMID: 39468695 Free PMC article. Review.
-
BCMA-targeted immunotherapy for multiple myeloma.J Hematol Oncol. 2020 Sep 17;13(1):125. doi: 10.1186/s13045-020-00962-7. J Hematol Oncol. 2020. PMID: 32943087 Free PMC article. Review.
-
Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity.J Immunol. 2010 May 1;184(9):4801-9. doi: 10.4049/jimmunol.0902385. Epub 2010 Apr 5. J Immunol. 2010. PMID: 20368271 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases